AI-enabled lung nodule management & risk stratification drives measurable ROI

Comparing a manual EMR-based referral system to a fully automated AI-powered incidental lung nodule (ILN) program

Certification

Redefining early intervention of lung disease starting with one of the deadliest, lung cancer

Optellum is a lung health company developing

the lung precision care platform to redefine the efficient management, early diagnosis, and optimal care of lung disease patients.

Optellum Ltd.

5 Kings Meadow, Osney Mead, Ferry Hinksey Road, Oxford,
Oxfordshire, England, OX2 0DP, United Kingdom

Optellum Inc.

TMC Innovation Institute, 2450 Holcombe Blvd, Suite X,
Houston, TX 77021, United States

Company

Partners

Resources

Providers

Patients

News

Website developed by